Oncologists' social networks

Post on 23-Aug-2014

9,737 views 1 download

description

An update of earlier presentations on physicians' social networks, but with a focus on oncology, one of the most e-reliant specialities in medicine. First presented at Sales & Marketing for Oncology Therapeutics, Brussels, 16 March 2010.

transcript

Physicians’Social NetworksAm Emergent New Engagement Channel in Oncology

Len StarnesHead of Digital Marketing & Sales General Medicine

Len StarnesHead of Digital Marketing & Sales General MedicineBayer Schering Pharma

Enhancing Sales & Marketing Performance for

Oncology TherapeuticsBrussels, 15 -16 March 2010

Agenda

The Big Bang

Global dimensions

Anatomies

Key learnings

Marketing beyond 2010

Source: Manhattan Research Strategic Insight, ePharma Physician v9.0 #4, 2009

Oncologists are highly e-reliant physicians

Gather productinformation

online> 75% of time

Physicians’ social networks

The Big Bang

Actually, it all began with sushi…

First reactions

What does it cost?

Is this something really new?

How does it work?

What is Sermo?

Great sushi!

Why is Pfizer always first?

I must talk to my brand teams about this

Black cat cartoon: with thanks to John Mack, Pharma Marketing Bloghttp://pharmamkting.blogspot.com/2007_10_01_archive

Transforming the way medical information is exchanged

Based on Pfizer/Sermo press release 15 October 2007http://www.sermo.com/news/media/press/pfizer

It’s all about…

Pharmaceuticalindustry

Initiating an open and honest discussion

Medical profession

Global dimensions

Physicians’ social networks

USA Setting the pace

Sermo Physician Connect

Student Doctor NetworkHealthevaRelaxdocSocialMD

SosidoClinical Village iMedExchange

TiromedOzmosis

Medical PlexusWithin3

Rad RoundsMyPacs

MedTrustMedicSpeak

PeerclipSyndicom Spineconnect

QuantiaMDMDsConnect

Number of networks

Diversity of networksAttracting VC

Pharma participation

112,000 members each

Significant long tail of niche players

EuropeHeterogeneous

doc2doc (Global)Doctors.net.uk (UK)

OnMedica (UK)Coliquio (D, CH, AT)

DocCheck Faces (Int’l)DocCheck Faces(D)DocCheck Faces (F)

DocCheck Faces (ES)DocCheck Faces (IT)

Dooox (D) Esanum (D)

Esanum (ES)Esanum (IT)

Esanum (CH)Esanum (AT)

Esanum (F)Docactus (F)

Med Universe (SE)

UK and Germany lead

Fewer players

Catching up with USA

17,000 members

Open and closed areas

Integrated with BMJ Group medical content

Global

130 countries

Focuses on D, CH, AT

16,000 members

Partnership with leading German medical

journal Ärzte Zeitung

Expanding to other EU countries 2010

Asia PacificEmergingopportunitiesHigh growth rates

Significant membershipnumbers

Good Doctor’s Forum (CN)China Asthma Alliance (CN)

dxy.com (CN) China obgyn.net (CN)

Orthochina (CN)Public networks (BBS) (CN)

Doctors Hangout (IN)Doctor.VG (IN)Medtitans (IN)

Protomedica (IN)HelloDr (IN)

Smartdoc (IN)M3.com (JP)

MedPeer (JP)Carenet (JP)

NM Online (JP)MT Pro (JP)

Medigate( KR)Misc medical news sites (KR)

Australian Doctor (AU)New Media Medicine (NZ)

China: www.dxy.cn

1.7m members - No authentication - 50% physicians - 30% biomed researchers - 20% medical studentsWith thanks to Kevin Lin, JSure Healthmedia

Japan: www.m3.com

Authenticated physicians 177,000 members

South Korea: Medigate

Authenticated physicians 67,000 members

Anatomies

Physicians’ social networks

AuthenticationAll specialitiesIncludes pharma

1st dimensiontaxonomy

AuthenticationSingle specialityIncludes pharma

AuthenticationAll specialitiesExcludes pharma

No authenticationAll specialitiesInc & excl pharma

Pure playSocial network only

SermoOzmosisColiquio

2nd dimensiontaxonomy

HybridSocial network + online med resource

Physician Connectdoc2docDoctors.net.uk

Pharma partnering options

Observation Research Engagement

Unmet needs

Treatment trends

Drug usage monitoring

Future Rx volume Unknown side-effects

Off-label usage

Early identification of critical issues

Post questions to a specialist community

Conduct surveys

Establish panels based on pre-selected criteria

Participation by scientific liaison staff in community discussions

Support speciality communities

Post information and services germane to discussions

Key learnings

Physicians’ social networks

Membership growing everywhere

Sustained growth in USA

Physicians in 2012: Manhattan Research,Taking the Pulse v9.0, 2009

Already using + very interested +

somewhat interested

6071

0

20

40

60

80

100

2008 2009

% respondents

Physician Online Communities: Social NetworkingManhattan Research, Taking the Pulse v8.0, 2008

Source: Coliquio

25,000 visits/month onDoctors.net.uk oncology area

Source: Doctors.net.uk, Feb 2010

Not just younger physicians

Sermo members markedly older than average internet

0

10

20

30

40

<30 30-39 40-49 50-59 60+Age of Sermo users

Per

cent

tota

l

Source: Sermo

Coliquio:

55 – 59 age group dominates

Similar age distribution in Europe

Physicians welcome pharma participation

…but only on their terms. No selling or advertising

Majority of physicians interestedin interacting with pharma

Source: Manhattan Research Strategic Insight, ePharma Physician v9.0 #6, 2009

I am interested in interacting with pharma on physicians’social networks (% e-physicians) 56%

Agree

44%Disagree

Top specialities interested

Source: Manhattan Research Strategic Insight, ePharma Physician v9.0 #6, 2009

Obgyns

OncologistsUrologists

NeurologistsDermatologists

What do physicians really want from pharma?

Source: Joel Selzer, Ozmosis, February 2010

Fast, simple, reliable answers to product questions

Peer-to-peer interaction and trusted feedback

Rep-like servicesbut on members’ terms

Pharma’s challenges mainly internal

Marketing

Sales

Medical & Scientific

Legal & Regulatory

Functional collaboration essential

Real-time poll update:http://polls.linkedin.com/poll-results/28204/lakmg

Physicians’ social networks

Marketing beyond 2010

During the next decade

Predominance of e-savvy physicians

Routine use ofSNs by majority

of physicians

Dwindling of sales forces

Predominance of multi-channel

engagement models

More physicians expecting

e-self servicefrom pharma

More physicians willing to engage

with pharma on SNs

Inevitable shift

Lessselling

Moredialogue

Fewer sales reps

Multi-disciplinary engagement teams

What will influence oncologists’ prescribing behaviour more

Open dialogue on social networks

Pharma marketingas we know it?or

Head of Digital Marketing & SalesGeneral MedicineBayer Schering Pharma

E: leonard.starnes@bayerhealthcare.comLkn: www.linkedin.com/in/lenstarnesTwt: www.twitter.com/lenstarnesSsh: www.slideshare.net/lenstarnesT: + 49 30 4681 4877M: + 49 175 438 4521I: www.bayerhealthcare.com

Len Starnes